MENU
OVID
AS OF
Dec 12 closing price
Price
$1.64
Change
-$0.01 (-0.61%)
Capitalization
116.79M
92 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
OVID
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Ovid Therapeutics (OVID) Ownership - Who owns Ovid Therapeutics?

Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Pharmaceuticals Major
Address
441 Ninth Avenue
Phone
+1 646 661-7661
Employees
40
Web
https://www.ovidrx.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
116.79M
P/E Ratio
N/A
Total Cash
25.6M
Projected Growth
N/A
Total Debt
13.76M
Revenue
6.61M
Risk (Beta)
0.49
Dividend Yield
N/A
Total Cash/Share
0.36
Total Debt/Equity
N/A
Revenue/Share
0.09 USD as % of share price

Fundamentals

OVID
Capitalization
117M
P/E Ratio
N/A
Risk (Beta)
0.49
Dividend Yield
N/A
Total Cash
25.6M
Total Cash/Share
0.36
Total Debt
13.8M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.09%
Revenue
6.61M
ROE
N/A
Book Value
44.7M
P/B Ratio
2.61
Cash Flow
N/A
Earnings
-0.5
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
71K
Current Ratio
4.24
Current Revenue Per Employee
5739.13
Dividends Per Share - Security
N/A
EBITDA
-40.45M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-43.64
Shares Held By Institutions
48.1M
Shares Outstanding - Current
71.2M
Total Liabilities
19.2M
Total Volume MTD
N/A
Value
N/A
Gain YTD
76.716
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
OVID
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. OVID showed earnings on November 12, 2025. You can read more about the earnings report here.
View AI-Driven Trading for OVID
A.I. Advisor
published General Information

General Information

Provides medicines to children and adults with neurological disorders

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
441 Ninth Avenue
Phone
+1 646 661-7661
Employees
40
Web
https://www.ovidrx.com